Search
for
Sort by
Research 151–180 of 1000+
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- Basal Cell Carcinoma, Hedgehog Signaling, and Targeted Therapeutics: The Long and Winding Road
- Catamenial-like seizure exacerbation in mice with targeted ablation of extrasynaptic δGABA-a receptors in the brain
- Platelet-rich plasma as a site-targeted approach in wound healing: a molecular perspective
- Methodologies to Evaluate the Hair Follicle-Targeted Drug Delivery Provided by Nanoparticles
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial
- Niosomes as Efficient Nanocarriers for Targeted Drug Delivery
- Probing neuronal functions with precise and targeted laser ablation in the living cortex
- Efficacy and safety of dual-targeted therapy for refractory inflammatory bowel disease: a retrospective case series from three tertiary general hospitals in China
- PLGA–Soya Lecithin Based Hybrid Nanocomposite for Targeted Topical Delivery of Resveratrol in Psoriasis Management
- Combination of Transcriptomics and Proteomics Reveals Differentially Expressed Genes and Proteins in the Skin of EDAR Gene-Targeted and Wildtype Cashmere Goats
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- De Novo-Designed Bifunctional Proteins for Targeted Protein Degradation
- Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations
- Pathological Skin Scarring: From Mechanism to Targeted Local Therapy
- PEGylated Flavonoid Aspasomes as a Brain-Targeted Nano-Vesicular Platform for Enhanced Neuroprotection in Stress-Induced Cognitive Dysfunction
- Hair Growth-Promoting Effects of a Multi-Targeted Cosmetic Formulation Containing PYGL, DP2, and 15-PGDH Inhibitors Developed Using AI-Based DeepZema® in Androgenetic Alopecia: A 24-Week Randomized Controlled Trial
- Exosomes in precision dermatology: From biomarkers to targeted therapeutics in personalized care
- De novo designed bifunctional proteins for targeted protein degradation
- Hidradenitis Suppurativa: From Physiopathologies to Targeted Therapeutics
- Hidradenitis Suppurativa: From Physiopathologies to Targeted Therapeutics
- <i>De novo</i> designed bifunctional proteins for targeted protein degradation
- Cinchonine‐loaded nanostructured lipid carriers for targeted delivery to hair follicles
- Cholecalciferol-grafted hollow mesoporous silica nanoparticles for targeted and sustained caffeine delivery in alopecia therapy
- Educating for Empathy: Impact of a Targeted Alopecia Areata Curriculum on Middle School Students
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- A Platform for Determining Medicinal Plants with Targeted 17β-Hydroxysteroid Dehydrogenase Modulation for Possible Hair Loss Prevention
- ISID1108 - Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata.